Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - WALGREEN CO | c65024e8vk.htm |
Exhibit 99.1
News From |
 |
Walgreens Corporate Communications • 200 Wilmot Road • Deerfield, Ill. 60015 • (847) 315-2500
Media Contact:
|
Tiffani Washington, 847-315-2925 | |
Investor Contacts:
|
Rick Hans, CFA, 847-315-2385 | |
| Lisa Meers, CFA, 847-315-2361 |
| FOR IMMEDIATE RELEASE | http://news.walgreens.com |
Walgreens May Sales Increase 7.0 Percent
DEERFIELD, Ill., June 3, 2011 — Walgreens (NYSE, NASDAQ: WAG) had May sales of
$6.08 billion, an increase of 7.0 percent from $5.69 billion for the same month in 2010.
Total front-end sales increased 5.5 percent in May, while comparable store front-end sales
increased 3.6 percent. Customer traffic in comparable stores increased 1.6 percent and basket size
increased 2.0 percent.
Prescriptions filled at comparable stores increased 7.1 percent in May. Calendar day shifts
positively impacted prescriptions filled in comparable stores by 1.7 percentage points. This
year’s May had one additional Tuesday and one fewer Saturday compared with May 2010.
May pharmacy sales increased 7.8 percent, while comparable pharmacy sales increased 6.7
percent. Calendar day shifts positively impacted pharmacy sales filled in comparable stores by 1.7
percentage points. Comparable pharmacy sales were negatively impacted by 1.8 percentage points due
to generic drug introductions in the last 12 months. Pharmacy sales accounted for 64.4 percent of
total sales for the month.
Sales in comparable stores (those open at least a year) increased 5.6 percent. The effect of
calendar day shifts positively impacted total comparable sales by 1.1 percentage points. As of May
1, Duane Reade stores are included in comparable store results.
Total sales for the third quarter of fiscal 2011 were $18.38 billion, up 6.8 percent from
$17.20 billion in the third quarter of fiscal 2010. Comparable store sales for the third quarter of
fiscal 2011 increased 4.1 percent, while front-end comparable store sales for the quarter
increased 3.9 percent. Prescriptions filled at comparable stores increased 4.5 percent in the
third quarter and comparable pharmacy sales increased 4.2 percent.
(more)
-2-
Calendar year-to-date sales were $30.08 billion, an increase of 8.0 percent from $27.85
billion in 2010.
Fiscal 2011 year-to-date sales for the first nine months were $54.22 billion, up 7.3 percent
from $50.55 billion in fiscal 2010.
Walgreens opened 12 stores during May, including six relocations, acquired one store and
closed two.
At May 31, Walgreens operated 8,171 locations in all 50 states, the District of Columbia,
Puerto Rico and Guam. That includes 7,714 drugstores, 192 more than a year ago, including 23 stores
acquired over the last 12 months. The company also operates worksite health centers, home care
facilities and specialty and mail service pharmacies. Its Take Care Health Systems subsidiary
manages more than 700 in-store convenient care clinics and worksite health and wellness centers.
May Comparable Sales and Prescriptions Filled
| Cough, Cold, | ||||||||||||||||
| Calendar Shift | Generics | Flu and Allergy | ||||||||||||||
| Reported | Impact | Impact | Impact | |||||||||||||
Total Comp Sales |
5.6 | % | 1.1 | % | -1.2 | % | 0.1 | % | ||||||||
Comp Front End |
3.6 | % | — | — | ||||||||||||
Comp Rx Sales |
6.7 | % | 1.7 | % | -1.8 | % | 0.1 | % | ||||||||
Comp Rx Scripts |
7.1 | %* | 1.7 | % | — | 0.2 | % | |||||||||
| * | Includes +2.9% from patients filling more 90-day prescriptions |
Please note: Sales numbers and the adjustments shown in the table are preliminary, unaudited
and subject to revision. Comparable stores are defined as those drugstore locations open for at
least 12 consecutive months without closure for seven or more consecutive days and without a major
remodel or a natural disaster in the past 12 months. Acquired operating locations and relocations
are not included as comparable stores for the first 12 months after the acquisition or relocation.
Statements in this release that are not historical are forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future performance and involve risks,
assumptions and uncertainties, including, but not limited to, changes in economic and business
conditions, competition, acquisitions, divestitures, vendor, payer and customer relationships,
outcomes of legal and regulatory matters and other factors described in Item 1A (Risk Factors) of
our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each of which is
incorporated herein by reference, and in other documents that we file or furnish with the
Securities and Exchange Commission.
(more)
-3-
Should one or more of these risks or uncertainties materialize, or should underlying assumptions
prove incorrect, actual results may vary materially from those indicated or anticipated by such
forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they are made. Except to the extent
required by law, Walgreens undertakes no obligation to update publicly any forward-looking
statement after the distribution of this release, whether as a result of new information, future
events, changes in assumptions or otherwise.
# # # # #